Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
Nutriband Inc. (NASDAQ: NTRB) has announced the appointment of World and European Wrestling Gold medalist and Olympic Silver medalist Anastasia Nichita to its Product Advisory Board. The appointment aims to expand the Nutriband Brand and promote its over-the-counter sports and consumer products internationally.
The company, which develops transdermal pharmaceutical products through its subsidiary Pocono Pharma, produces multiple products including AI Tape. This product combines traditional kinesiology tape benefits with soothing and therapeutic ingredients in a proprietary adhesive mix.
Nutriband Inc. (NASDAQ: NTRB) ha annunciato la nomina della medaglia d'oro mondiale ed europea di lotta e medaglia d'argento olimpica Anastasia Nichita nel suo Consiglio Consultivo per i Prodotti. L'appuntamento ha l'obiettivo di espandere il marchio Nutriband e promuovere i suoi prodotti sportivi e di consumo da banco a livello internazionale.
L'azienda, che sviluppa prodotti farmaceutici transdermici attraverso la sua controllata Pocono Pharma, produce diversi prodotti tra cui AI Tape. Questo prodotto combina i benefici del tradizionale nastro di kinesiotaping con ingredienti lenitivi e terapeutici in una miscela adesiva proprietaria.
Nutriband Inc. (NASDAQ: NTRB) ha anunciado el nombramiento de la medallista de oro mundial y europea de lucha, así como medallista de plata olímpica Anastasia Nichita en su Consejo Asesor de Productos. El nombramiento tiene como objetivo expandir la marca Nutriband y promover sus productos deportivos y de consumo de venta libre a nivel internacional.
La empresa, que desarrolla productos farmacéuticos transdérmicos a través de su subsidiaria Pocono Pharma, produce múltiples productos, incluyendo AI Tape. Este producto combina los beneficios del kinesiotape tradicional con ingredientes calmantes y terapéuticos en una mezcla adhesiva patentada.
Nutriband Inc. (NASDAQ: NTRB)는 세계 및 유럽 레슬링 금메달리스트이자 올림픽 은메달리스트 Anastasia Nichita를 제품 자문위원회에 임명했다고 발표했습니다. 이번 임명은 Nutriband 브랜드를 확장하고 국제적으로 자사 판매 스포츠 및 소비자 제품을 홍보하기 위한 것입니다.
이 회사는 자회사인 Pocono Pharma를 통해 경피 약제를 개발하며, AI Tape를 포함한 여러 제품을 생산합니다. 이 제품은 전통적인 키네시오 테이프의 이점과 진정 및 치료 성분을 독점적인 접착 혼합물로 결합합니다.
Nutriband Inc. (NASDAQ: NTRB) a annoncé la nomination de la médaillée d'or mondiale et européenne de lutte ainsi que médaillée d'argent olympique Anastasia Nichita au sein de son Conseil Consultatif de Produits. Cette nomination vise à élargir la marque Nutriband et à promouvoir ses produits sportifs et de consommation en vente libre à l'international.
La société, qui développe des produits pharmaceutiques transdermiques par l'intermédiaire de sa filiale Pocono Pharma, produit plusieurs articles, dont AI Tape. Ce produit combine les avantages du tape de kinésiologie traditionnel avec des ingrédients apaisants et thérapeutiques dans un mélange adhésif exclusif.
Nutriband Inc. (NASDAQ: NTRB) hat die Ernennung der Welt- und Europameisterin im Wrestling sowie Silbermedaillengewinnerin der Olympischen Spiele Anastasia Nichita in ihren Produktberatungsrat bekannt gegeben. Die Ernennung zielt darauf ab, die Nutriband-Marke auszubauen und ihre rezeptfreien Sport- und Verbraucherprodukte international zu fördern.
Das Unternehmen, das transdermale Pharmazeutika über seine Tochtergesellschaft Pocono Pharma entwickelt, stellt mehrere Produkte her, darunter AI Tape. Dieses Produkt kombiniert die Vorteile von traditionellem Kinesiology Tape mit beruhigenden und therapeutischen Inhaltsstoffen in einer proprietären Klebemischung.
- Strategic addition of high-profile Olympic athlete to Advisory Board enhances brand visibility
- Potential expansion of international market presence for OTC products
- None.
ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European Wrestling Gold medalist and Olympic Silver medalist Anastasia Nichita has been appointed to its Product Advisory Board to expand the Nutriband Brand and promote it’s over the counter sports and consumer products internationally.
"We are very excited to add Anastasia to our team. We believe her experience and insights will be invaluable in expanding the Nutriband Brand and strengthening our consumer product categories worldwide," said CEO Gareth Sheridan.
Nutriband Inc. through its wholly own subsidiary Pocono Pharma engages in the production of multiple products including AI Tape, which is designed to combine many of the traditional benefits of kinesiology tape with the addition of soothing and therapeutic ingredients held in suspension with a proprietary adhesive mix.
About Nutriband Inc.
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The Company's website is www.nutriband.com. Any material contained in or derived from the Company's websites or any other website is not part of this press release.
Forward-Looking Statements
Certain statements contained in this press release, including, without limitation, statements containing the words ‘'believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Form 10-K for the year ended January 31, 2024, filed May 1, 2024, the Forms 10-Q’s filed subsequent to the Form 10-K in 2024, and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.
Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: info@nutriband.com
SOURCE: Nutriband Inc.
FAQ
Who is the new advisory board member appointed to Nutriband (NTRB) in February 2025?
What is the purpose of Anastasia Nichita's appointment to NTRB's advisory board?
What is Nutriband's (NTRB) AI Tape product?
Which subsidiary of Nutriband (NTRB) produces the AI Tape product?
